title: [Disseminated renal adenocarcinoma. Developmental study].
abstract: A study was undertaken on 57 patients diagnosed as having disseminated renal adenocarcinoma. The interval between the onset of symptomatology and diagnosis ranged from 1 to 48 months. The tumor frequently metastasized to lungs and bone. To evaluate survival, this patient population was divided into two groups: those who underwent nephrectomy, 17 patients (9 patients also underwent lymphadenectomy), and those who were put on drug therapy alone. No significant difference was observed with respect to survival for both patient groups.
authors.forename: C
authors.initials: C
authors.lastname: Domínguez
authors.forename: E
authors.initials: E
authors.lastname: Broseta
authors.forename: F
authors.initials: F
authors.lastname: Boronat
authors.forename: B
authors.initials: B
authors.lastname: Llopis
authors.forename: R
authors.initials: R
authors.lastname: Martínez
authors.forename: J F
authors.initials: JF
authors.lastname: Jiménez-Cruz
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged
vernacular_title: Adenocarcinoma renal diseminado. Estudio evolutivo.